Silo Pharma (SILO) has selected Alphaledger/Simplify Target 12% Distribution Fund as a core component of its real-world asset investment strategy on the Solana blockchain. This strategic allocation aligns with Silo’s approach to treasury diversification and digital asset integration. The Alphaledger T12 Fund is a digital-native investment vehicle that provides access to tokenized real-world assets on public blockchains. Designed to deliver high monthly income, the fund leverages a diversified portfolio of alternative, income-generating strategies. Operating on Solana, it offers high-speed, low-cost, and verifiable investment pathways into tokenized financial instruments. Its blend of high-yield, low-duration fixed income, hedged credit, and option strategies provides a differentiated approach to income generation while managing risk.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SILO:
- Silo Pharma Shareholders Approve Key Proposals at Annual Meeting
- Psychedelic: Clearmind enrolls last patient in first cohort of CMND-100 trial
- Silo Pharma provides update on SPC-15 advancement, digital asset program
- Psychedelic: PharmAla launches portal for MDMA prescribers, therapists
- Silo Pharma announces initial Bitcoin purchase